Liquid Dosage
Therapeutical Proteins
Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.
The GEA Advantage
As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.
Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.
A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.
As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.
Продукты и технологии
Отображение 4 из 11
Aseptic valves & components
Aseptic valves face exceptionally high demands within UltraClean and Aseptic processes. You can be assured that they all provide highest quality in terms of hygienic design and sustainability.
Hygienic pumps
GEA Hilge offers a versatile range of centrifugal and positive displacement pumps for a wide variety of sensitive applications in the beverage, food and pharmaceutical industries.
Lyophilizers (Pharma Freeze Dryers)
GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.
Блок прессования гомогенизатора
Компрессионные головки компании GEA являются сердцем гомогенизатора, так как они запускают процесс гомогенизации, перекачивая продукт под высоким давлением, пока он не попадет в гомогенизирующий клапан.
Downloads
Аналитика GEA
Kytero 10 — большое начинается с малого
GEA kytero 10 — это мощный ускоритель последнего поколения для исследователей и разработчиков в области биофармацевтики, пищевой промышленности и производства новых продуктов питания.
Новый рецепт для гурманов
А что, если бы для производства вашего любимого шоколада не были нужны какао-бобы, а кофе был бы местного производства? Поскольку изменение климата, рост цен и этические проблемы затронули два наших самых любимых продукта, ученые переосмысливают способ их производства, используя микробы, а не монокультуры. Цель — сохранить вкус, аромат и свойства кофе и шоколада, сведя к минимуму выбросы углекислого газа и повысив качество продуктов питания.
В меню: яйца, полученные отвечающим принципам устойчивого развития методом
GEA помогает клиентам тестировать и масштабировать производство альтернативных яичных продуктов и ингредиентов, изготовляемых методом прецизионной ферментации.
